SCHEMBL4591367

SCHEMBL4591367

O=C1C2[C@H]3CC[C@H](C3)[C@H]2C(=O)N1c1ccc(O)c(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.52
SMN1; SMN2 Q16637 9/20 0.51
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
POLB P06746 2/20 0.49
HPGD P15428 1/20 0.49
MAPT P10636 1/20 0.48
GAA P10253 3/20 0.45
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
RAB9A P51151 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746126 1.00 LMNA (0.52) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3198050 1.00 LMNA (0.52) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL6746128 1.00 LMNA (0.52) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3198060 1.00 LMNA (0.52) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3194443 0.82 SMN1; SMN2 (0.54) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3194451 0.82 SMN1; SMN2 (0.54) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL26109454 0.80 ALDH1A1 (0.56) SMN1; SMN2MEN1KMT2AMAPTALDH1A1
SCHEMBL3199533 0.77 SMN1; SMN2 (0.62) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3199524 0.77 SMN1; SMN2 (0.62) LMNASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3187800 0.76 SMN1; SMN2 (0.50) LMNASMN1; SMN2MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379249-A4 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL MYERS SQUIBB CO (US) 2008-01-09 EP claimed
EP-1379249-A1 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION Bristol-Myers Squibb Company (US) 2004-01-14 EP claimed
WO-2002067939-A1 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-06 WO claimed